Cancer Updates, News View this post on Instagram Kelsey Hampton walks us through the important breast cancer news that came out of the European Society of Medical Oncology (ESMO) meeting. Kelsey is a research grants manager at Susan G. Komen. Have questions for Kelsey? Drop them in the comments and she’ll answer 👇🏼 A post shared by Susan G. Komen (@susangkomen) on Oct 18, 2020 at 3:55pm PDT Leading cancer doctors just wrapped up the annual European Society of Medical Oncology – or ESMO – meeting, where major breast cancer news was announced. Kelsey Hampton, a research grants manager at Susan G. Komen, shares the results of three clinical trials – and what they could mean for patients. Thanks to the hard work of clinicians and scientists, several new treatment options are on the horizon for patients with triple negative breast cancer, a subtype that is very hard to treat, and metastatic breast cancer, for which there is currently no cure. << Previous Post How Community Was Created for... Komen Blog Read More Next Post >> Susan G. Komen and Natura... Komen Blog Read More Related Stories Previous Next Komen Blog Komen Researcher Alex Cheng is... Read More Komen Blog Brinker Awardee Dr. Laura Esserman... Read More Komen Blog Komen Asks Congress for Policies... Read More Komen Blog 8 Ways to Live a... Read More Komen Blog Dr. Elizabeth Mittendorf Wants To... Read More Komen Blog In Case You Missed It... Read More Komen Blog Komen and E! News Give... Read More Komen Blog The Hardest Year Read More Komen Blog Patient Groups to Congress: End... Read More Komen Blog Moments of Gratitude Read More Komen Blog How Do You Thank Someone... Read More Komen Blog Community Badge Read More Komen Blog Breast Cancer and My Family... Read More Komen Blog Thank You, Donors, For Funding... Read More Komen Blog Breast Cancer: I Can’t Afford... Read More Komen Blog Passion for Health and Reducing... Read More Komen Blog What is Left Unsaid Does... Read More Komen Blog Komen Donor Townhall – Mission... Read More